FRANKLIN, Tenn.--(BUSINESS WIRE)--BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) announced today that Dr. Samuel E. Lynch, CEO and president, will provide an update of corporate activities at the 2008 UBS Global Life Sciences Conference on Thursday, September 25 at 9:30 a.m. EDT. The presentation will take place in Carnegie Hall Ballroom B at the Grand Hyatt Hotel in New York City.
